GB9714675D0 - Novel composition - Google Patents

Novel composition

Info

Publication number
GB9714675D0
GB9714675D0 GBGB9714675.7A GB9714675A GB9714675D0 GB 9714675 D0 GB9714675 D0 GB 9714675D0 GB 9714675 A GB9714675 A GB 9714675A GB 9714675 D0 GB9714675 D0 GB 9714675D0
Authority
GB
United Kingdom
Prior art keywords
novel composition
novel
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9714675.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9714675.7A priority Critical patent/GB9714675D0/en
Publication of GB9714675D0 publication Critical patent/GB9714675D0/en
Priority to KR1020007000202A priority patent/KR20010021644A/ko
Priority to IDW20000035A priority patent/ID24191A/id
Priority to EA200000112A priority patent/EA200000112A1/ru
Priority to JP50818599A priority patent/JP2002508003A/ja
Priority to AU93401/98A priority patent/AU9340198A/en
Priority to CA002295822A priority patent/CA2295822A1/en
Priority to IL13386998A priority patent/IL133869A0/xx
Priority to BR9810996-0A priority patent/BR9810996A/pt
Priority to PCT/EP1998/004971 priority patent/WO1999002142A2/en
Priority to PL98338017A priority patent/PL338017A1/xx
Priority to EP98946294A priority patent/EP0996466A2/en
Priority to APAP/P/1999/001728A priority patent/AP2000001728A0/en
Priority to HU0003074A priority patent/HUP0003074A3/hu
Priority to CN98806975A priority patent/CN1262627A/zh
Priority to TR2000/00074T priority patent/TR200000074T2/xx
Priority to SK7-2000A priority patent/SK72000A3/sk
Priority to DZ980166A priority patent/DZ2556A1/xx
Priority to ZA9806138A priority patent/ZA986138B/xx
Priority to MA25165A priority patent/MA24604A1/fr
Priority to CO98039260A priority patent/CO4950552A1/es
Priority to PE1998000612A priority patent/PE99699A1/es
Priority to ARP980103371A priority patent/AR016128A1/es
Priority to NO20000107A priority patent/NO20000107L/no
Priority to OA1200000006A priority patent/OA11276A/en
Priority to BG104119A priority patent/BG104119A/xx
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
GBGB9714675.7A 1997-07-11 1997-07-11 Novel composition Pending GB9714675D0 (en)

Priority Applications (26)

Application Number Priority Date Filing Date Title
GBGB9714675.7A GB9714675D0 (en) 1997-07-11 1997-07-11 Novel composition
SK7-2000A SK72000A3 (en) 1997-07-11 1998-07-07 Novel composition comprising an ssri and a beta-blocker
APAP/P/1999/001728A AP2000001728A0 (en) 1997-07-11 1998-07-07 Novel composition.
CN98806975A CN1262627A (zh) 1997-07-11 1998-07-07 新型组合物
EA200000112A EA200000112A1 (ru) 1997-07-11 1998-07-07 Новая композиция
JP50818599A JP2002508003A (ja) 1997-07-11 1998-07-07 新規な組成物
AU93401/98A AU9340198A (en) 1997-07-11 1998-07-07 Novel composition
CA002295822A CA2295822A1 (en) 1997-07-11 1998-07-07 Novel composition
IL13386998A IL133869A0 (en) 1997-07-11 1998-07-07 Novel composition novel formulations comprising an ssri in combination with a beta blocker
BR9810996-0A BR9810996A (pt) 1997-07-11 1998-07-07 Composição farmacêutica
PCT/EP1998/004971 WO1999002142A2 (en) 1997-07-11 1998-07-07 Novel composition comprising an ssri and a beta-blocker
PL98338017A PL338017A1 (en) 1997-07-11 1998-07-07 Novel composition
EP98946294A EP0996466A2 (en) 1997-07-11 1998-07-07 Novel composition comprising an ssri and a beta-blocker
KR1020007000202A KR20010021644A (ko) 1997-07-11 1998-07-07 신규한 조성물
HU0003074A HUP0003074A3 (en) 1997-07-11 1998-07-07 Pharmaceutical composition comprising ssri and betha-blocking agent
IDW20000035A ID24191A (id) 1997-07-11 1998-07-07 Komposisi baru
TR2000/00074T TR200000074T2 (tr) 1997-07-11 1998-07-07 Yeni terkip
DZ980166A DZ2556A1 (fr) 1997-07-11 1998-07-08 Compositions nouvelles d'inhibiteur sélectif de réabsorption de sérotonine et d'un beta-bloquant.
ZA9806138A ZA986138B (en) 1997-07-11 1998-07-10 Combinations of selective serotonin re-update inhibitors and B-blockers.
MA25165A MA24604A1 (fr) 1997-07-11 1998-07-10 Compositions nouvelles d'inhibiteur selectif de reabsorption de serotonine et d'un b-bloquant
CO98039260A CO4950552A1 (es) 1997-07-11 1998-07-10 Nueva composicion lectivos de la reabsorcion de seotonina y un bloqueador b
PE1998000612A PE99699A1 (es) 1997-07-11 1998-07-10 Composicion que comprende un inhibidor selectivo de la reabsorcion de serotonina y un �-bloqueante
ARP980103371A AR016128A1 (es) 1997-07-11 1998-07-10 Una composicion farmaceutica que comprende un inhibidor de recaptacion de serotonina y un beta-bloqueante y el empleo de la misma para la produccion de unmedicamento.
NO20000107A NO20000107L (no) 1997-07-11 2000-01-10 Ny blanding
OA1200000006A OA11276A (en) 1997-07-11 2000-01-11 Novel composition comprising an ssri and a beta-b locker.
BG104119A BG104119A (en) 1997-07-11 2000-02-01 A new composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9714675.7A GB9714675D0 (en) 1997-07-11 1997-07-11 Novel composition

Publications (1)

Publication Number Publication Date
GB9714675D0 true GB9714675D0 (en) 1997-09-17

Family

ID=10815744

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9714675.7A Pending GB9714675D0 (en) 1997-07-11 1997-07-11 Novel composition

Country Status (26)

Country Link
EP (1) EP0996466A2 (xx)
JP (1) JP2002508003A (xx)
KR (1) KR20010021644A (xx)
CN (1) CN1262627A (xx)
AP (1) AP2000001728A0 (xx)
AR (1) AR016128A1 (xx)
AU (1) AU9340198A (xx)
BG (1) BG104119A (xx)
BR (1) BR9810996A (xx)
CA (1) CA2295822A1 (xx)
CO (1) CO4950552A1 (xx)
DZ (1) DZ2556A1 (xx)
EA (1) EA200000112A1 (xx)
GB (1) GB9714675D0 (xx)
HU (1) HUP0003074A3 (xx)
ID (1) ID24191A (xx)
IL (1) IL133869A0 (xx)
MA (1) MA24604A1 (xx)
NO (1) NO20000107L (xx)
OA (1) OA11276A (xx)
PE (1) PE99699A1 (xx)
PL (1) PL338017A1 (xx)
SK (1) SK72000A3 (xx)
TR (1) TR200000074T2 (xx)
WO (1) WO1999002142A2 (xx)
ZA (1) ZA986138B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE457169T1 (de) 1998-10-15 2010-02-15 Imp Innovations Ltd Verbindungen für die behandlung von gewichtsverlust
IL142896A0 (en) 1998-11-02 2002-04-21 Elan Corp Plc Multiparticulate modified release composition
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
RU2230556C2 (ru) 1999-10-29 2004-06-20 Эро-Селтик, С.А. Препаративные формы гидрокодона с контролируемым высвобождением
GB0004003D0 (en) * 2000-02-22 2000-04-12 Knoll Ag Therapeutic agents
AU2002227383B2 (en) 2000-10-30 2004-07-08 Euro-Celtique S.A. Controlled release hydrocodone formulations
EP1793818A2 (en) * 2004-09-17 2007-06-13 Neurocure Ltd. Pindolol for treating premenstrual syndrome and premenstrual dysphoric disorder
CN100469356C (zh) * 2006-09-08 2009-03-18 山东益康药业有限公司 复方阿替洛尔缓释片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2732335C2 (de) * 1976-07-27 1983-01-20 Sandoz-Patent-GmbH, 7850 Lörrach Tablette zur enteralen Verabreichung von Indolyloxyalkanolamin-Derivaten
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
AU6776196A (en) * 1995-08-16 1997-03-12 Eli Lilly And Company Potentiation of serotonin response
EP0792649A1 (en) * 1996-02-29 1997-09-03 Eli Lilly And Company Treatment of sleep disorders

Also Published As

Publication number Publication date
NO20000107D0 (no) 2000-01-10
BR9810996A (pt) 2000-08-08
DZ2556A1 (fr) 2003-02-15
PL338017A1 (en) 2000-09-25
CO4950552A1 (es) 2000-09-01
ID24191A (id) 2000-07-13
AP2000001728A0 (en) 2000-03-31
HUP0003074A3 (en) 2001-12-28
JP2002508003A (ja) 2002-03-12
CN1262627A (zh) 2000-08-09
SK72000A3 (en) 2000-12-11
EA200000112A1 (ru) 2000-10-30
AR016128A1 (es) 2001-06-20
WO1999002142A2 (en) 1999-01-21
TR200000074T2 (tr) 2000-05-22
BG104119A (en) 2000-12-29
WO1999002142A3 (en) 1999-04-15
PE99699A1 (es) 1999-12-21
CA2295822A1 (en) 1999-01-21
MA24604A1 (fr) 1999-04-01
EP0996466A2 (en) 2000-05-03
OA11276A (en) 2003-07-31
IL133869A0 (en) 2001-04-30
HUP0003074A2 (hu) 2001-01-29
AU9340198A (en) 1999-02-08
KR20010021644A (ko) 2001-03-15
NO20000107L (no) 2000-01-10
ZA986138B (en) 2000-01-10

Similar Documents

Publication Publication Date Title
GB9704524D0 (en) Composition
GB9715203D0 (en) Composition
GB9713620D0 (en) Composition
GB9711683D0 (en) Composition
GB9726543D0 (en) Novel compositions
GB9715489D0 (en) Composition
GB9714010D0 (en) Composition
GB9726777D0 (en) Composition
PL338017A1 (en) Novel composition
EP0958806A4 (en) HAIR COLORING COMPOSITION
GB9701031D0 (en) Composition
GB9714359D0 (en) Composition
GB9726284D0 (en) Composition
GB9826467D0 (en) Composition
GB9724975D0 (en) Composition
GB9705813D0 (en) Novel compositions
GB9705110D0 (en) Composition
EG23068A (en) Pesticidale composition
ZA986934B (en) Composition
GB9718910D0 (en) Composition
GB9722706D0 (en) Composition
GB9722705D0 (en) Composition
GB9723007D0 (en) Composition
GB9708197D0 (en) Composition
GB9726205D0 (en) Composition